In a groundbreaking move, Evolute Bioscience has signed an agreement pledging to end all experiments on animals formerly required in its pharmacology education classes and to instead use virtual simulation software, provided free of charge by PETA India in partnership with Himachal Pradesh-based simulation developer Simcology India. This decision positions the Trichy startup as one of the most progressive biotech education institutions in Tamil Nadu and sets a replicable template for science colleges across India.
What Evolute Bioscience Has Done and Why It Matters
Who Is Evolute Bioscience and Where Is It Based
Evolute Bioscience is a proprietorship firm incorporated on November 11, 2020, with its registered office at Kaveri Nagar, Woraiyur, Trichy, Tamil Nadu. Classified as a micro enterprise, the company is primarily engaged in educational support services under research and experimental development in natural sciences and engineering.
The firm was founded as an initiative by NIT alumni to establish a technicalized environment focused on the research needs of students pursuing undergraduate and postgraduate studies in life science, pharma, and biotechnology. Its core mission is to bridge the gap between theoretical learning and practical implementation by introducing all possible technical resources to students and preparing them for industrial employment.
Despite its micro-enterprise scale, Evolute Bioscience's decision to eliminate animal testing from its curriculum is not a small act. It is a signal of where responsible biotech education in India is heading.
What Agreement Was Signed and What It Covers
Per the agreement with PETA India, Evolute Bioscience has permanently prohibited the use of living and deceased animals and animals' parts in undergraduate and postgraduate pharmacology education, teaching, training, and demonstrations, as well as for research and thesis work in its postgraduate curriculum. Additionally, Evolute Bioscience has permanently canceled its plans to procure at least 50 mice annually for a new educational stream focused on disease model-related animal testing.
The firm has also cancelled its plans related to 60 zebrafish that were to be used for pharmacological experimentation purposes. Under the transition timeline, this will be completed as soon as a non-animal simulation module is finalised through Simcology. Upon the availability of this alternative, Evolute Bioscience will halt all zebrafish experiments.
Who Are the Partners Behind This Decision
What Role PETA India Played in the Transition
This move was inspired by discussions with PETA India, which highlighted the benefits of non-animal research and education methods. PETA partnered with Simcology India, a company based in Himachal Pradesh, to provide the free software.
As part of its broader campaign to replace the use of animals for teaching and training across the country, PETA India has teamed up with Simcology to offer the company's virtual animal laboratory simulation software, and also with the Bureau for Health and Education Status Upliftment, New Delhi, to offer Ex-Pharm computer assisted learning software free of cost to pharmacology educators.
PETA India scientist Anjana Aggarwal stated clearly that modern technology provides better and more ethical ways to train pharmacology students, noting that animals like mice are not always relevant to human pharmacology education, and encouraging other institutions to follow Evolute Bioscience's lead.
What Simcology's Software Actually Does
SIMCOLOGY, a leading animal simulator software, has recreated a virtual animal laboratory for students to learn without having to maim or kill animals for dissection. SIMCOLOGY is designed to facilitate pharmacology education, empower self-learning, and reduce the number of animals used for experimentation. Conceptualized and developed in India, SIMCOLOGY addresses local education regulations that call for replacing the use of animals in teaching with modern, non-animal teaching methods, covering different types of experiments in pharmacology.
Simcology's interactive software allows pharmacology students to conduct experiments using computer-assisted learning methods while sparing the lives of animals who otherwise may be forced to inhale or consume chemicals, be infected with diseases, mutilated, and then killed via suffocation or neck dislocation.
The significance here goes beyond ethics. A virtual lab can be reset, repeated, and scaled without additional cost, consumables, or the procurement delays associated with live animal acquisition. This is a practical advantage that any lean biotech education firm can act on immediately.
What the Science Says About Virtual Simulation in Pharmacology
How Computer Simulation Compares to Live Animal Testing for Education
The scientific case for replacing live animal experiments in pharmacology education is well established. Research published in peer-reviewed literature confirms that computer simulation models (CSMs) can be used repeatedly and independently by students, avoiding unnecessary experimentation and the pain and trauma caused to animals. Studies found that test scores and feedback showed better understanding of drug mechanisms gained in a shorter time when students used CSMs compared to conventional animal procedures.
The University Grants Commission banned animal dissection in life sciences and zoology courses, and the Medical Council of India and Pharmacy Council of India both prohibited the use of animals to train undergraduate medical and pharmacy students, respectively, favouring non-animal techniques instead.
In 2022, India's National Medical Commission updated its guidelines for pharmacology education, recommending non-animal methods and making some animal experiments optional. Evolute Bioscience's decision goes further than compliance. It represents a complete institutional commitment to this regulatory direction, rather than a minimum-threshold adjustment.
What Students Gain from Virtual Pharmacology Training
Modern computer assisted learning (CAL) platforms for pharmacology include features such as lab manuals, virtual experiments, performance analytics, downloadable observation sheets, and exam-mode simulations. These tools enable pharmacy, medical, and veterinary students to perform realistic virtual experiments aligned with the curriculum standards of the Pharmacy Council of India and National Medical Commission.
Many students are uncomfortable with animal dissection and experimentation, and virtual simulations offer a cruelty-free alternative that is also cost-effective and sustainable. This shift to virtual learning not only spares animal lives but also prepares students with modern tools for their future careers in medicine and science.
Research from the peer-reviewed literature also highlights a long-overlooked problem: a significant number of students at every educational level are uncomfortable with the use of animals in dissection and experimentation, and some even turn away from scientific careers rather than violating their principles. Removing this barrier directly widens the talent pipeline entering Indian biotech and pharmaceutical research.
What the Leadership of Evolute Bioscience Said
Who Made the Decision and What Was Their Reasoning
Preyenga Saravanan, Managing Director of Evolute Bioscience, stated that the firm greatly appreciates PETA India for donating Simcology software that allows the company to replace its experiments on animals in undergraduate and postgraduate educational curricula while also enhancing the quality of learning for its students.
This statement is important to read carefully. Saravanan did not frame the decision purely as an ethical concession. She explicitly connected it to improved educational outcomes. That framing matters because it gives other institutions a practical, results-oriented reason to follow suit, not just a moral one.
Evolute Bioscience's stated mission has always been to bridge the gap between theoretical learning and practical implementation. The adoption of Simcology's virtual simulation software is entirely consistent with this founding purpose, applying technology to deepen student competency without the logistical and ethical costs of live animal procurement.
Why This Decision Has Wider Implications for Indian Biotech Education
What This Means for Other Pharmacology Programs in India
Computer software programs can be used repeatedly, saving both time and money, and they also help maintain ecological balance by sparing animals' lives. These software programs replace experiments in which animals may be forced to consume food or water laced with a chemical, forced to inhale a chemical, or deliberately infected with diseases and mutilated, after which they would be killed via suffocation or neck dislocation.
The model demonstrated by Evolute Bioscience is financially accessible. The software was donated at zero cost through the PETA India and Simcology partnership. This removes the primary barrier that most micro and small biotech education firms cite when asked why they have not yet transitioned to non-animal pharmacology teaching methods.
The Pharmacy Council of India has issued a notification confirming that wherever animal experiments are being conducted using simulations, the requirement of an Animal House and registration with CPCSEA is not required for such institutions. This regulatory clarity eliminates a major compliance concern and further reduces the cost burden of switching to virtual simulation.
Who Else Should Follow Evolute Bioscience's Example
Evolute Bioscience's decision sets an important example for other institutions to follow, promoting compassion and innovation in education. Hundreds of private pharmacology and biotech training institutes operate across Tamil Nadu alone, many of them at the micro and small enterprise scale. Most are still procuring and using live animals for routine pharmacology demonstrations that serve no research purpose beyond instruction. Simcology's software addresses precisely this use case.
The broader Indian pharmaceutical industry, which depends on a pipeline of well-trained pharmacology graduates, also has a stake in this transition. Students trained on virtual simulation platforms are comfortable with computer-assisted drug analysis, a skill set that is increasingly central to modern pharmaceutical research, clinical trials management, and regulatory submissions.